Skip to content
Crystal Reels House

Users Discontinuing Anti-Obesity Injections Put On Pounds Four Times Faster Than People Using Diet and Exercise

Image of pharmaceutical syringe and weighing machine
Weight management involves long-term strategies.

Fresh analysis reveals that people who discontinue popular slimming jabs like Mounjaro or Wegovy can put back on lost weight much more quickly than those who end traditional lifestyle programs.

Findings released in a major health publication shows that while overweight individuals often shed a large proportion of their body weight while on the medication, the weight comes back at an average rate of nearly a kilo each month once they quit.

"Users using these drugs should be aware of the danger of rapid rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.

This pace of recovery means a reversion to original weight in about a year and a half.

Analyzing Therapies

The research, which looked at dozens of trials involving over 9,000 of participants, compared the outcomes of these new drugs with conventional dieting.

Scientists emphasize that individuals who lose weight through diet and exercise typically see a more gradual weight regain—around 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Nutrition scientists believe the mode of action of the injections is key to understanding the heightened weight return.

These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone levels several times higher than normal may cause the body to produce less of its endogenous hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.

"Withdrawal of this hormone supplement means hunger is uncontrolled, making binge eating much more probable."

A Lifelong Issue?

The NHS recommend the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.

Many experts argue that, considering the significant potential of relapse, the therapy is often ongoing.

This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the persistent nature of excess weight," comparing it to managing diseases like high blood pressure.

Patient Experiences

Individuals who have discontinued the jabs report a sudden resurgence of appetite.

"It felt as if a switch flipping and you become ravenous," described one woman.

This difficulty is exacerbated if individuals have not established permanent dietary or behavioural changes during therapy.

Growing Use

Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.

  • Adoption is higher among women compared to men.
  • The 40s and 50s demographic shows the greatest usage rates.
  • A large proportion obtain the drugs through private healthcare rather than the NHS.

Ultimately, researchers stress that while GLP-1 drugs are potent agents for weight loss, they are not a permanent solution and long-term success likely depends on combined lifestyle management.

By

Haley Lin

A seasoned casino analyst with over a decade of experience in slot game reviews and gambling industry trends.

Crystal Reels House

Type to search articles.